Skip to content
(480) 999-0905
FacebookLinkedin
Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.
Arizona's Only Accredited Master Surgeon – Greg J. Marchand M.D.
Arizona's Only Accredited Master Surgeon – Greg J. Marchand M.D.
  • Dr. Greg Marchand
    • About Dr. Marchand
    • Funding & Independence
  • Fellowship
  • Research
    • Publications
    • Research Methodology
    • Clinical Trials
    • Research Team
  • Newsroom
    • Press Kit
    • Expert Commentary
    • Media Coverage
    • Video Appearances
  • Collaborate
  • Contact
  • Dr. Greg Marchand
    • About Dr. Marchand
    • Funding & Independence
  • Fellowship
  • Research
    • Publications
    • Research Methodology
    • Clinical Trials
    • Research Team
  • Newsroom
    • Press Kit
    • Expert Commentary
    • Media Coverage
    • Video Appearances
  • Collaborate
  • Contact

New in EJOG: Surgical Management of Interstitial (Cornual) Pregnancy

October 10, 2026Laparoscopy, Minimally Invasive Surgery, OBGYNBy Maria Sainz

My team’s newest systematic review and meta-analysis is now online in the European Journal of Obstetrics & Gynecology and Reproductive Biology, Volume 327, December 2026, article 115472.

Surgical management of interstitial (cornual) pregnancy: a systematic review of perioperative and reproductive outcomes with meta-analysis of hospital stay

Marchand G, Anderson D, Mera S, O’Connell B, Robinson M, Palma A, Gonzalez Herrera D, Ibrahim F, Azadi A.

Read it free for 50 days

Elsevier has given me a share link that opens the final published article with no paywall, no registration and no fee, through November 28, 2026.

Read the full article free (through November 28, 2026)

After that date: journal page · PubMed, PMID 42854538 · DOI 10.1016/j.ejogrb.2026.115472

Why we did this review

Interstitial pregnancy, which many surgeons still call cornual pregnancy, implants in the part of the tube that runs through the uterine wall. It is uncommon, and it is dangerous, because the surrounding muscle lets the pregnancy grow longer before anything gives way. Over the last two decades management has moved from laparotomy to laparoscopic cornual resection and cornuostomy, and in most centers that shift is complete.

What has not moved at the same pace is the evidence. Nearly everything published on this condition is a case report or a small series. When a patient asks whether she can carry a pregnancy after cornual surgery, and whether her uterus will hold, there is very little in the literature that honestly answers her. That gap is what we set out to map.

How we did it

We searched PubMed/MEDLINE, Embase, Web of Science and CENTRAL through 5 July 2026, along with ClinicalTrials.gov and the reference lists of everything we retrieved. The protocol was registered prospectively with PROSPERO (CRD420261424165) and the review follows PRISMA. Screening and data extraction were done independently by two reviewers, with a third resolving disagreements. Screening identified 353 reports.

What we found

  • Only two observational cohorts, 102 patients between them, reported hospital stay in a form that could be pooled. Laparoscopy was associated with a stay 1.25 days shorter than laparotomy (95% CI -1.75 to -0.76 days, I² 0%). Under a more conservative Knapp-Hartung model that interval widens to -4.47 to 1.96 days, which is a fair reminder of what two studies can and cannot carry.
  • Transfusion could not be pooled, because one comparative cohort did not report counts specific to interstitial pregnancy. The data do not establish that the two routes are equivalent on the other perioperative outcomes.
  • Fertility outcomes could not be pooled either. Populations, endpoints and denominators were simply not compatible across reports.
  • Subsequent uterine ruptures are documented in the literature, but the number of treated cases is not a valid denominator for rupture risk. Nobody should be reassuring patients on the strength of the current evidence.

What it means

The direction of travel looks right. Laparoscopy is probably the shorter stay and it is already the default in most hands. The part that should bother us is how thin the reproductive data are for a condition whose patients are overwhelmingly young and want more children. Future reports need to say which treatment was given, who intended to conceive, what happened in the next pregnancy, and who was lost to follow-up. Without those four things we will still be writing this same review in ten years.

Congratulations and thanks to Dakota Anderson, Sarah Mera, Brooklynn O’Connell, McKenna Robinson, Adriana Palma, Daniela Gonzalez Herrera, Fatma Ibrahim and Dr. Ali Azadi for their work on this one.

Greg J. Marchand, MD, FACS, FACOG, FICS

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook

Like this:

Like Loading…

Related

Ectopic Pregnancylaparoscopymeta-analysisobgynPregnancyresearchSystematic Review
Related posts
American Journal of Obstetrics & Gynecology MFM (AJOG MFM) journal cover
Fresh Off the Press in AJOG MFM: Marchand Institute’s New Meta-Analysis on Single- vs. Double-Layer Uterine Closure and Cesarean Scar Outcomes
July 28, 2026
New Research from Dr. Greg Marchand: Evaluating the Impact of Robotic Assistance in Single-Site Hysterectomy
February 20, 2026
Exciting News: Dr. Marchand’s Latest Meta-Analysis on Opportunistic Salpingectomy for Epithelial Ovarian Cancer Prevention is Published and Open Access!
February 5, 2026
New Systematic Review and Meta-Analysis: Comparative Risk of Neonatal Ischemic Encephalopathy in Operative Vaginal Delivery vs. Cesarean at Complete Dilation – Now Online in AJP!
January 29, 2026
We're thrilled to announce the publication of a groundbreaking systematic review and meta-analysis led by Dr. Greg Marchand and the dedicated research team at the Marchand Institute for Minimally Invasive Surgery! Titled "Laparoendoscopic Single-Site Surgery Versus Conventional Laparoscopic Surgery in Ovarian Cystectomy: A Meta-Analysis", this comprehensive study compares two advanced minimally invasive techniques for removing benign ovarian cysts — Laparoendoscopic Single-Site Surgery (LESS) (using a single small incision, often hidden at the umbilicus for superior cosmetic results) and Conventional Laparoscopic Surgery (CLS) (using multiple small incisions). Analyzing data from 9 studies involving 1,368 women, the meta-analysis reveals compelling insights: LESS is associated with longer operative times (by about 9.4 minutes on average), likely due to the technical demands of working through a single port. However, patients undergoing LESS benefit from a shorter hospital stay (reduced by approximately 0.26 days). Importantly, there are no significant differences in key safety outcomes: postoperative pain scores (at 6 and 24 hours), estimated blood loss, need for opioid analgesics, drop in hemoglobin levels, or overall complication rates. These findings strengthen the evidence that LESS is a safe, effective, and viable alternative to conventional laparoscopy for women with benign ovarian cysts — offering faster recovery and excellent cosmetic advantages while maintaining comparable safety and pain profiles. This work adds valuable high-level evidence to the field of minimally invasive gynecologic surgery and reflects the Marchand Institute's ongoing commitment to advancing women's health through rigorous, volunteer-driven research. Read the full open-access paper for free today: PubMed Central (PMC) (recommended - full text & PDF): https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/ Direct PDF download: https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/pdf/jcm-14-08739.pdf Published in Journal of Clinical Medicine (December 10, 2025) – DOI: 10.3390/jcm14248739 We invite clinicians, researchers, and patients interested in the latest advancements in minimally invasive surgery to explore this important contribution. A huge thank you to our incredible team of researchers, students, and collaborators who made this possible — all volunteer efforts dedicated to improving outcomes for women everywhere! Visit us at marchandinstitute.org to learn more about our ongoing research, educational programs, and mission to push the boundaries of minimally invasive techniques.
Newest Paper on Laparoscopic Single Site Ovarian Cystectomy Online Now!
January 1, 2026
New Systematic Review Reveals Gynecologic Surgeons Achieve Superior Outcomes in Pediatric Adnexal Mass Surgery – Now Freely Available Online!
December 18, 2025
Articles
  • New in EJOG: Surgical Management of Interstitial (Cornual) Pregnancy
    October 10, 2026
  • American Journal of Obstetrics & Gynecology MFM (AJOG MFM) journal cover
    Fresh Off the Press in AJOG MFM: Marchand Institute’s New Meta-Analysis on Single- vs. Double-Layer Uterine Closure and Cesarean Scar Outcomes
    July 28, 2026
  • New Research from Dr. Greg Marchand: Evaluating the Impact of Robotic Assistance in Single-Site Hysterectomy
    February 20, 2026
  • Exciting News: Dr. Marchand’s Latest Meta-Analysis on Opportunistic Salpingectomy for Epithelial Ovarian Cancer Prevention is Published and Open Access!
    February 5, 2026
  • New Systematic Review and Meta-Analysis: Comparative Risk of Neonatal Ischemic Encephalopathy in Operative Vaginal Delivery vs. Cesarean at Complete Dilation – Now Online in AJP!
    January 29, 2026
  • We're thrilled to announce the publication of a groundbreaking systematic review and meta-analysis led by Dr. Greg Marchand and the dedicated research team at the Marchand Institute for Minimally Invasive Surgery! Titled "Laparoendoscopic Single-Site Surgery Versus Conventional Laparoscopic Surgery in Ovarian Cystectomy: A Meta-Analysis", this comprehensive study compares two advanced minimally invasive techniques for removing benign ovarian cysts — Laparoendoscopic Single-Site Surgery (LESS) (using a single small incision, often hidden at the umbilicus for superior cosmetic results) and Conventional Laparoscopic Surgery (CLS) (using multiple small incisions). Analyzing data from 9 studies involving 1,368 women, the meta-analysis reveals compelling insights: LESS is associated with longer operative times (by about 9.4 minutes on average), likely due to the technical demands of working through a single port. However, patients undergoing LESS benefit from a shorter hospital stay (reduced by approximately 0.26 days). Importantly, there are no significant differences in key safety outcomes: postoperative pain scores (at 6 and 24 hours), estimated blood loss, need for opioid analgesics, drop in hemoglobin levels, or overall complication rates. These findings strengthen the evidence that LESS is a safe, effective, and viable alternative to conventional laparoscopy for women with benign ovarian cysts — offering faster recovery and excellent cosmetic advantages while maintaining comparable safety and pain profiles. This work adds valuable high-level evidence to the field of minimally invasive gynecologic surgery and reflects the Marchand Institute's ongoing commitment to advancing women's health through rigorous, volunteer-driven research. Read the full open-access paper for free today: PubMed Central (PMC) (recommended - full text & PDF): https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/ Direct PDF download: https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/pdf/jcm-14-08739.pdf Published in Journal of Clinical Medicine (December 10, 2025) – DOI: 10.3390/jcm14248739 We invite clinicians, researchers, and patients interested in the latest advancements in minimally invasive surgery to explore this important contribution. A huge thank you to our incredible team of researchers, students, and collaborators who made this possible — all volunteer efforts dedicated to improving outcomes for women everywhere! Visit us at marchandinstitute.org to learn more about our ongoing research, educational programs, and mission to push the boundaries of minimally invasive techniques.
    Newest Paper on Laparoscopic Single Site Ovarian Cystectomy Online Now!
    January 1, 2026
What patients say
  • 14517468_1646198135690553_6990924301147850409_n“I delivered both my beautiful babies with Dr. Marchand and I wouldn’t have it any other way! Every doctor visit up until I was in labor was great, he took all the time to answer all my questions. I didn’t feel rushed in and rushed out of the office. The office was always very clean! The staff were always very friendly. When I was in labor he made sure my birth plan was the most important thing! He always had my best interest in hand! My first delivery I was induced and it took 3 long days and Marchand kept checking on me all hours of the night!! If I did it all over again I’d definitely use Marchand as my OB again!”

    Related

    Alex S.
  • “We congratulate Dr. Greg J. Marchand as SRC’s first Surgeon of Excellence in Minimally Invasive Surgery (SOEMIS) in the United States. To achieve SOEMIS accreditation, Dr. Marchand invited SRC to complete a rigorous onsite inspection and thorough chart review to illustrate his compliance with the program. Dr. Marchand and his practice exemplify SRC’s commitment to patient safety and care.”

    Related

    Ashley DuBray, Senior Director of the Surgical Review Corporation
  • “I initially met Dr. Marchand upon an emergency room visit due to complications during my first pregnancy. My husband and I had recently moved from out of state. Not knowing many people here, in a scary situation and finding myself hospitalized was made a lot easier once we met Dr. Marchand who we decided would be the best doctor to see my care through the pregnancy and ultimate c-section. He always had time for our questions even when we knew he had many other patients. He did a great job with the surgery and follow up care and was very pleasant, patient and professional throughout the process. When we decided to have another baby, he saw us through another pregnancy and c-section and continues to be my OB of choice. I would recommend him in a heartbeat to any girlfriends I know.”

    Related

    Megan E. of Gilbert, AZ
  • “Growing up I have had my fair share of woman health issue from Endometriosis, PCOS, Severe Pelvic Pain, Loss of Pregnancy and Infertility and more pelvic surgeries than I can count. I have seen many different doctors till about 6-7 years ago when I needed emergency surgery and met Dr. Marchand and now I refuse to go to any one else. With the many issues I have had both Dr. Marchand as well as his whole office staff have been so helpful I couldn’t be more grateful. It’s very hard to find an honest, trustworthy doctor these days but rest assured you can’t go wrong with Dr. Greg Marchand. They are open late and almost always can fit you into the schedule for emergencies and you can always reach him no matter what time it is if you have questions. Dr. Marchand is an amazing surgeon and loves what he does. He has delivered many friends and family’s children and hope that one day he will be able to deliver mine as well.”

    Related

    Tomi M. of Gilbert
Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.
© Greg Marchand MD

Loading Comments...
%d

    Research repository

    Every paper, abstract and presentation Dr. Marchand publishes is listed in his open research repository. Subscribe by RSS to be notified whenever new work is added.

    Browse the repository All research (RSS)

    Topic feeds: Peer-reviewed articles | Conference presentations